EXHIBIT 10.10 THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT (i) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO, (ii) AN OPINION OF...Adeza Biomedical Corp • August 6th, 2004 • In vitro & in vivo diagnostic substances • California
SERVICE AGREEMENTService Agreement • October 27th, 2004 • Adeza Biomedical Corp • In vitro & in vivo diagnostic substances • California
EXHIBIT 10.11 THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT (i) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO, (ii) AN OPINION OF...Adeza Biomedical Corp • August 6th, 2004 • In vitro & in vivo diagnostic substances • California
SERVICE AGREEMENT This agreement ("Agreement") made as of March 31, 1999 by and between SNYDER HEALTHCARE SALES INC., a New Jersey corporation ("SHS") and ADEZA BIOMEDICAL CORPORATION, a Delaware corporation ("CLIENT")Service Agreement • August 6th, 2004 • Adeza Biomedical Corp • In vitro & in vivo diagnostic substances • California
NETAdeza Biomedical Corp • December 6th, 2004 • In vitro & in vivo diagnostic substances • California
BETWEENExclusive License Agreement • October 27th, 2004 • Adeza Biomedical Corp • In vitro & in vivo diagnostic substances • Pennsylvania
RECITALSAgreement and Release • December 7th, 2004 • Adeza Biomedical Corp • In vitro & in vivo diagnostic substances • California
EXHIBIT 10.9 THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT (i) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO, (ii) AN OPINION OF...Adeza Biomedical Corp • August 6th, 2004 • In vitro & in vivo diagnostic substances • California
AGREEMENT ---------Adeza Biomedical Corp • October 27th, 2004 • In vitro & in vivo diagnostic substances
AGREEMENT AND PLAN OF MERGER by and among CYTYC CORPORATION (“Parent”) AUGUSTA MEDICAL CORPORATION (“Purchaser”) and ADEZA BIOMEDICAL CORPORATION (the “Company”) Dated as of February 11, 2007Agreement and Plan of Merger • February 12th, 2007 • Adeza Biomedical Corp • Instruments for meas & testing of electricity & elec signals • Delaware
AGREEMENT AND PLAN OF MERGER (hereinafter referred to as this “Agreement”), dated as of February 11, 2007 by and among Cytyc Corporation, a Delaware corporation (“Parent”), Augusta Medical Corporation, a Delaware corporation and a direct wholly-owned subsidiary of Parent (“Purchaser”), and Adeza Biomedical Corporation, a Delaware corporation (the “Company”).
ADEZA BIOMEDICAL CORPORATION AMENDED AND RESTATED MANAGEMENT CONTINUITY AGREEMENTManagement Continuity Agreement • March 15th, 2007 • Adeza Biomedical Corp • Instruments for meas & testing of electricity & elec signals • California
This Amended and Restated Management Continuity Agreement (the “Agreement”) is dated as of January 12, 2007, by and between Durlin E. Hickok (“Employee”) and Adeza Biomedical Corporation., a Delaware corporation (the “Company” or “Adeza”). This Agreement amends sections 2(b)(i) – (iv) and section 5(a) of the Management Continuity Agreement entered into by and between Employee and the Company on October 21, 2004. This Agreement is intended to provide Employee with certain benefits described herein upon the occurrence of specific events.
ADEZA BIOMEDICAL CORPORATION AMENDED AND RESTATED MANAGEMENT CONTINUITY AGREEMENTManagement Continuity Agreement • February 16th, 2007 • Adeza Biomedical Corp • Instruments for meas & testing of electricity & elec signals • California
This Amended and Restated Management Continuity Agreement (the “Agreement”) is dated as of January 12, 2007, by and between Robert O. Hussa (“Employee”) and Adeza Biomedical Corporation., a Delaware corporation (the “Company” or “Adeza”). This Agreement amends sections 2(b)(i) — (iv) and section 5(a) of the Management Continuity Agreement entered into by and between Employee and the Company on October 21, 2004. This Agreement is intended to provide Employee with certain benefits described herein upon the occurrence of specific events.
RECITALSManagement Continuity Agreement • October 27th, 2004 • Adeza Biomedical Corp • In vitro & in vivo diagnostic substances • California
NET INDUSTRIAL SPACE LEASE by and between Tasman V, LLC as Landlord and Adeza Biomedical Corporation as TenantLease • November 7th, 2006 • Adeza Biomedical Corp • Instruments for meas & testing of electricity & elec signals • California
THIS LEASE, dated July 12, 2006 for reference purposes only, is made by and between Tasman V, LLC (“Landlord”) and Adeza Biomedical Corporation (“Tenant”), to be effective and binding upon the parties as of the date of the designated signatories to the Lease shall have executed this Lease (the “Effective Date of this Lease”).
THIRD AMENDMENT TO LEASELease • March 14th, 2006 • Adeza Biomedical Corp • Instruments for meas & testing of electricity & elec signals
This Amendment date July 15, 2005 for reference purposes only, is made by and between Tasman V, LLC (hereinafter sometime called “Lessor”) and Adeza Biomedical Corporation (hereinafter sometimes called “Tenant”) for Premises commonly known as 1240 Elko Drive, Sunnyvale, California.
FIFTH AMENDMENT TO SERVICE AGREEMENTService Agreement • March 15th, 2007 • Adeza Biomedical Corp • Instruments for meas & testing of electricity & elec signals
This fifth amendment (the “Fifth Amendment”) made as of May 14, 2006 (the “Effective Date”), by and between VENTIV COMMERCIAL SERVICES, LLC, a New Jersey limited liability company (formerly known as Ventiv Pharma Services, LLC and Ventiv Health U.S. Sales, LLC) (“Ventiv”) and ADEZA BIOMEDICAL CORPORATION, a Delaware corporation (“Adeza”) to a certain Service Agreement made as of March 31, 1999 by and between Ventiv and Adeza, as amended by a First Amendment made as of March 8, 2001 (the “First Amendment”), a Second Amendment made as of July 22, 2002 (the “Second Amendment”), a Third Amendment made as of May 15, 2004 (the “Third Amendment”), and a Fourth Amendment made as of March 30, 2006 (the “Fourth Amendment”) (the Service Agreement as amended by the First Amendment, Second Amendment, Third Amendment and Fourth Amendment shall be referred to herein as the “Amended Agreement”). Ventiv and Adeza may each be referred to herein as a “Party” and collectively, the “Parties”.
EXHIBIT 10.12 INDEMNIFICATION AGREEMENT THIS AGREEMENT (the "Agreement") is made effective as of ______________ __, 2004 by and between Adeza Biomedical Corporation, a Delaware corporation (the "Company") and __________ ("Indemnitee"). WITNESSETH...12 Indemnification Agreement • August 6th, 2004 • Adeza Biomedical Corp • In vitro & in vivo diagnostic substances • Delaware
RECITALSInvestors' Rights Agreement • August 6th, 2004 • Adeza Biomedical Corp • In vitro & in vivo diagnostic substances • California
AGREEMENTAgreement • August 6th, 2004 • Adeza Biomedical Corp • In vitro & in vivo diagnostic substances • England
